With more than 25 years of experience serving clients globally, Simulations Plus stands as a premier provider in the biopharma sector, offering advanced software and consulting services that enhance drug discovery, development, research, clinical trial operations, regulatory submissions, and commercialization. Our comprehensive biosimulation solutions integrate artificial intelligence/machine learning (AI/ML), physiologically based pharmacokinetics (PBPK), quantitative systems pharmacology/toxicology (QSP/QST), and population PK/PD modeling approaches. We also deliver simulation-enabled performance and intelligence solutions alongside medical communications support for clinical and commercial drug development. Our cutting-edge technology is licensed and utilized by leading pharmaceutical, biotechnology, and regulatory agencies worldwide.
We offer #1-ranked, easy-to-use software (GastroPlus®, ADMET Predictor®, DILIsym®, NAFLDsym®, MonolixSuite®, and more) to bridge data mining and compound library screening with QSAR models, PK/PD model development, and PBPK/TK modeling & simulation in animals and humans following administration around the body, and quantitative systems pharmacology approaches. Our clinical simulations and medical communications software platforms (Pro-ficiency Performance Management and Panorama) support our clients' study quality and communications through drug development, regulatory submission, approval, and commercialization.
For more information, visit our website at https://www.simulations-plus.com/.